FDA Drug Application (022311) for MOZOBIL by GENZYME

Back to FDA Applications sponsored by GENZYME

Application Number022311
Product Number001
FormSOLUTION;SUBCUTANEOUS
Dosage24MG/1.2ML (20MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameMOZOBIL
Active IngredientPLERIXAFOR



Back to FDA Applications sponsored by GENZYME